GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » Interest Coverage

Epigral (NSE:EPIGRAL) Interest Coverage : 136.70 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Epigral Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Epigral's Operating Income for the three months ended in Mar. 2025 was ₹1,394 Mil. Epigral's Interest Expense for the three months ended in Mar. 2025 was ₹-10 Mil. Epigral's interest coverage for the quarter that ended in Mar. 2025 was 136.70. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Epigral's Interest Coverage or its related term are showing as below:

NSE:EPIGRAL' s Interest Coverage Range Over the Past 10 Years
Min: 5.74   Med: 13.44   Max: 103.07
Current: 13.6


NSE:EPIGRAL's Interest Coverage is ranked better than
56.91% of 1186 companies
in the Chemicals industry
Industry Median: 9.72 vs NSE:EPIGRAL: 13.60

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Epigral Interest Coverage Historical Data

The historical data trend for Epigral's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Epigral Interest Coverage Chart

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Interest Coverage
Get a 7-Day Free Trial 6.08 13.28 11.65 5.74 13.60

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.41 10.03 5.35 - 136.70

Competitive Comparison of Epigral's Interest Coverage

For the Chemicals subindustry, Epigral's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigral's Interest Coverage Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Epigral's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Epigral's Interest Coverage falls into.


;
;

Epigral Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Epigral's Interest Coverage for the fiscal year that ended in Mar. 2025 is calculated as

Here, for the fiscal year that ended in Mar. 2025, Epigral's Interest Expense was ₹-425 Mil. Its Operating Income was ₹5,782 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹4,523 Mil.

Interest Coverage=-1* Operating Income (A: Mar. 2025 )/Interest Expense (A: Mar. 2025 )
=-1*5781.6/-425.2
=13.60

Epigral's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the three months ended in Mar. 2025, Epigral's Interest Expense was ₹-10 Mil. Its Operating Income was ₹1,394 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹4,523 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*1394.3/-10.2
=136.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Epigral  (NSE:EPIGRAL) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Epigral Interest Coverage Related Terms

Thank you for viewing the detailed overview of Epigral's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigral Business Description

Traded in Other Exchanges
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral Headlines

No Headlines